Search hospitals > California > Santa Barbara

Ridley-Tree Cancer Center

Claim this profile
Santa Barbara, California 93105
Conducts research for Breast Cancer
Conducts research for Cancer
Conducts research for Tumors
Conducts research for Adenocarcinoma
Conducts research for Non-Hodgkin's Lymphoma
33 reported clinical trials
3 medical researchers
Photo of Ridley-Tree Cancer Center in Santa BarbaraPhoto of Ridley-Tree Cancer Center in Santa BarbaraPhoto of Ridley-Tree Cancer Center in Santa Barbara

Summary

Ridley-Tree Cancer Center is a medical facility located in Santa Barbara, California. This center is recognized for care of Breast Cancer, Cancer, Tumors, Adenocarcinoma, Non-Hodgkin's Lymphoma and other specialties. Ridley-Tree Cancer Center is involved with conducting 33 clinical trials across 67 conditions. There are 3 research doctors associated with this hospital, such as Mukul Gupta, MD, Shane E. Cotter, and Justin C. Voog.

Area of expertise

1Breast Cancer
Ridley-Tree Cancer Center has run 10 trials for Breast Cancer. Some of their research focus areas include:
ER positive
HER2 negative
Stage IV
2Cancer
Ridley-Tree Cancer Center has run 5 trials for Cancer. Some of their research focus areas include:
Stage III
Stage IV
TSC1 positive

Top PIs

Clinical Trials running at Ridley-Tree Cancer Center

Prostate Cancer
Breast Cancer
Prostate Adenocarcinoma
Non-Small Cell Lung Cancer
Lung Cancer
Adenocarcinoma
Recurrence
Tumors
Bone Metastasis
Gene Mutation
Image of trial facility.

Hormone + Radiation Therapy

for Prostate Cancer

This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
Image of trial facility.

Apalutamide + Hormone and Radiation Therapies

for Prostate Cancer

This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting2 awards Phase 3

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Ridley-Tree Cancer Center?
Ridley-Tree Cancer Center is a medical facility located in Santa Barbara, California. This center is recognized for care of Breast Cancer, Cancer, Tumors, Adenocarcinoma, Non-Hodgkin's Lymphoma and other specialties. Ridley-Tree Cancer Center is involved with conducting 33 clinical trials across 67 conditions. There are 3 research doctors associated with this hospital, such as Mukul Gupta, MD, Shane E. Cotter, and Justin C. Voog.